After one month, eight out of thirty children taking Pycnogenol didnt require rescue inhalers anymore and eighteen children were completely off the inhaler after the three-month supplementation with Pycnogenol
Compounded multi-agent topicalscombining a DHT blocker, a vasodilator, an anti-inflammatory, and an antifungal in one applicationcan address several pathways simultaneously, improving adherence by reducing the number of products a patient has to apply
GLP-1 Program: Starting Tier First Month: $99 with promotion (regularly $199), then $199/month ongoing
Hellerup, February 11, 2026 Executive Board Board of Directors Independent Auditors Report To the shareholders of Ascendis Pharma A/S Opinion We have audited the consolidated financial statements and the parent financial statements of Ascendis Pharma A/S for the financial year January 1 to December 31, 2025, which comprise statements of profit or loss and other comprehensive income, statements of financial position, statements of changes in equity, cash flow statement and notes, including material accounting policy information, for the Group as well as the Parent
It contributes to the induction of ER stress